Search

The concept of placebo has had a long history in medicine, and has evolved over time with the introduction of randomised controlled trials for testing health treatment, the increasing research done around the psychotherapies, the development of complementary and alternative medicine approaches to health, as well as the conceptual contributions from academic disciplines like psychology and anthropology. In recent years, discourses about placebo have pursued a number of key directions, and the current review paper explores these developments. For example, psychology has looked at placebo in terms of classical conditioning and the role of anxiety. Anthropology on the other hand has focused on the role of meaning and ritual in the placebo effect and psychotherapy research has encouraged an examination of the effects of the therapeutic relationship. Our review paper concludes by outlining directions ahead for future scholarship and research. [ABSTRACT FROM AUTHOR]

This paper examines the primarily sociological and anthropological literature that discusses the current challenges posed by the 'modernisation' of herbal knowledge through its co-option by biomedicine. Through this examination we identify evidence for a trend which suggests this co-option is a tactical strategy to preserve biomedical dominance through control of the knowledge base of 'other' medicines. Having identified such a trend, we examine the invention of the term 'complementary and alternative medicine' (CAM), suggesting that the universalising of non-orthodox health care practices under this construct is a problematic symptom of biomedical co-option. We then go on to argue that a possible outcome of biomedical co-option is an epistemological bifurcation between 'traditionally' orientated and 'biomedically' informed herbal knowledge and practice, a phenomenon whose implications demand serious recognition and analysis, not only in the academic literature, but also in wider public debates. [ABSTRACT FROM AUTHOR]

Through interviews with users and providers of anti-ageing medicine in Australia as well as the analysis of various internet sites, anti-ageing clinics, journals and magazines dealing with anti-ageing medicine, this paper will argue that the anti-ageing industry in Australia is an example of how ‘mediascapes’ operate, seeking in this case to replicate the American model while developing a more localized practice meeting local needs, cultural orientations and regulatory frameworks. The products being studied here include some which have been on the market for many years in the Complementary and Alternative Medicine (CAM) industry, but have only recently been rebranded as ‘anti-ageing’. These include vitamins, anti-oxidants, supplements such as beta-carotene, selenium and coenzyme Q10, homeopathic products, exercise and diet programs. Other products that have been recently labelled as ‘anti-ageing’ and are included in this study are hormone therapies, testosterone, melatonin, Human Growth Hormone (HGH), and Dehydroepiandrosterone (DHEA). These products have been previously trialled and used in the treatment of medical problems such as heart disease, sexual dysfunction, cognitive and memory loss problems, and hormonal deficiency. Current medical research on stem cells, particularly embryonic stem cells, has also fallen within the realm of anti-ageing treatments developed from this research area and available primarily in countries with limited regulation and control over the use and availability of embryonic stem cells in the context of the private anti-ageing clinic. The differences and similarities between the practice of anti-ageing medicine in Australia and in America highlight current tensions and correspondences in the manner in which ageing is being constructed, managed and experienced. They are indicative of the impact that social policy directions, regulatory frameworks and economic policies have on the way in which ageing individuals and society at large approach the experience of old age. [ABSTRACT FROM AUTHOR]